Dorzagliatin (development code HMS5552, brand name MYHOMSIS) is a first-in-class, dual-acting allosteric oral glucokinase activator (GKA). It is used for the treatment of type 2 diabetes mellitus (T2DM).
The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.